BackNissan Medical Industries Overview

Nissan Medical Industries EBIT

Track Nissan Medical Industries's EBIT ($27M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$13.56M
↑ 19.31% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$26.67M
↑ 218.97% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Nissan Medical Industries (NISA.TA) FAQ

The latest EBIT for NISA.TA is $27M as of June 2026. That compares with $8.4M in the prior-year period — up 219.0% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside Nissan Medical Industries's historical trend and sector peers before judging valuation or financial health.

Over the past year, NISA.TA's EBIT moved from $8.4M to $27M — a 219.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nissan Medical Industries's operating scale or balance-sheet position.

Against its sector companies, NISA.TA currently prints $27M for EBIT, while the sector average sits near $2.4T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Nissan Medical Industries's growth, margins, and balance sheet.

A EBIT figure of $27M for NISA.TA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.

After noting NISA.TA's EBIT ($27M), review year-over-year change from $8.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.